1M6MYTD1Y5YMAX
Loading quotes...
Core data
| Name | L&G Pharma Breakthrough UCITS ETF USD - ACC |
| Issuer | L&G |
| Fund domicile | Ireland |
| TER | 0,49% |
| Fund size | 19.43m€ |
| P/E ratio | 18.75 |
| P/B ratio | 3.88 |
| Inception date | 01/23/2018 |
| Website |
Partner news
AdvertisementDeep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | ETLI.DE |
London Stock Exchange | BIGT.L |
London Stock Exchange | BIOT.L |
Amsterdam | BIOT.AS |
Frankfurt | ETLI.F |
Düsseldorf | ETLI.DU |
London | BIGT.L |
Milan | BIOT.MI |
München | ETLI.MU |
SIX | BIOT.SW |
Hamburg | ETLI.HM |
Composition
| Holdings | Share |
|---|---|
| 5.42% | |
| 4.43% | |
| 3.69% | |
| 3.50% | |
| 3.40% | |
| 3.29% | |
| 3.11% | |
| 3.10% | |
| 3.03% | |
| 3.01% |
As of 08/10/2026
Top sectors
| Sector | Share |
|---|---|
Health Care | 81.17% |
Materials | 5.52% |
Top countries
| Country | Share |
|---|---|
USA | 62.51% |
Japan | 11.20% |
China | 3.30% |
Sweden | 3.10% |
Australia | 3.06% |
Denmark | 3.01% |
Netherlands | 2.98% |
South Korea | 2.89% |
Switzerland | 2.88% |
France | 2.79% |
Discover assets
Shareholders of L&G Pharma Breakthrough UCITS ETF USD - ACC also invest in the following assets






